Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Effective dandruff treatment requires delivering antifungal agents to the scalp follicular infundibulum.

A new supplement may treat hair loss by targeting multiple causes like inflammation and stress.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A new side effect of aromatic retinoid treatment is soft nails.

LLLT devices for hair loss need more research to define proper guidelines.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

PRP treatment increased hair density, especially in men and younger patients with AGA.

The new drug carriers show promise for better targeting and treating ovarian cancer.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Squarticles, tiny particles made from sebum-derived lipids, can effectively deliver minoxidil, a hair growth drug, directly to hair follicles and skin cells, with less skin penetration and more tolerability.

Hidradenitis suppurativa is a chronic skin disorder linked to genetics, lifestyle, and immune issues, treatable with medications and surgery.

Hidradenitis suppurativa is a chronic skin disorder linked to genetics, lifestyle, and immune issues, treatable with medication and sometimes surgery.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

The ACP's migraine treatment guidelines are flawed and don't prioritize patient safety.

Upadacitinib effectively treats pyoderma gangrenosum.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Nanocarriers improve acne treatment by enhancing drug delivery and reducing side effects.

Laser and Eflornithine are more effective for hair removal than traditional methods.

ThriveCo Anti-Dandruff Pre-Shampoo Treatment effectively reduces dandruff and improves scalp health without side effects.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Sirtuin 1 could be a potential drug target for treating hypertrophic scars.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

A3B5 can reduce skin pigmentation and slow melanoma growth.